Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treating sickle cell disease with a pyruvate kinase R activating compound

Treating sickle cell disease with a pyruvate kinase R activating compound

US Patent 11980611 · Granted May 14, 2024

Estimated economic value: $216,614,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-CD38 antibody and use thereof2025
Methods using HDAC11 inhibitors2025
Methods using HDAC11 inhibitors2025
Inhibiting CREB binding protein (CBP)2025
Inhibiting cyclic AMP-responsive element-binding protein (CREB)2025
Compounds and compositions for the inhibition of NAMPT2025
Compounds and compositions for the inhibition of NAMPT2025
Compounds and compositions for the inhibition of NAMPT2025
Compounds and compositions for the inhibition of NAMPT2025
Bicyclic [4,6,0] hydroxamic acids as HDAC inhibitors2025
Bicyclic [4,6,0] hydroxamic acids as HDAC inhibitors2025
Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inh2025